Nowadays, "Simei", GLP-1, and weight loss have become hot topics among the public, and Novo Nordisk has seized the opportunity to deliver impressive performance in the weight loss sector in the first half of the year.
Recently, Danish pharmaceutical giant Novo Nordisk (NVO. US) released its first half 2024 performance report, with revenue of 133.409 billion Danish kroner, approximately 19.5 billion US dollars, a year-on-year increase of 24% in Danish kroner and a ...
阅读全文